Douglas R. Jeffery, MD, PhD Director of the Multiple Sclerosis Center Advance Neurology and Pain at Cornerstone Health Care Advance, NC
Clyde E. Markowitz, MD Associate Professor of Neurology Director of the MS Center University of Pennsylvania Philadelphia, PA
Amy Perrin Ross, APN, MSN, CNRN, MSCN Neuroscience Program Coordinator Loyola University Medical Center Maywood, IL
AMA PRA Category 1 Credit TM
Nurses: 0.5 Contact Hour
Nurse Practitioners: 0.5 Contact Hour Medium
An interactive CME/CE-certified newsletter series for neurologists, nurse practitioners, advanced practice nurses, neurological nurses, and other health care professionals on the diagnosis, treatment, and monitoring of patients with multiple sclerosis (MS).
Clinicians who treat patients with MS can improve outcomes by: 1. More consistently monitoring response to therapy and adjusting therapy when needed for individual patients with MS. 2. Developing optimal evidence-based tailored treatment approaches for patients with MS. 3. Updating clinical practice patterns in response to new clinical evidence and emerging therapeutic advances. The goal of this continuing education series is to enhance the ability of neurologists and other clinicians to provide personalized treatment plans for patients with MS, ultimately improving outcomes for patients.
. Target Audience
This program has been developed for general neurologists, advanced practice nurses, nurse practitioners, neurological nurses, and other health care clinicians involved in the care of patients with multiple sclerosis.
Upon completion of this educational activity, the participant should be able to:
Define the appropriate role of current and emerging oral disease-modifying therapies for patients with relapsing-remitting multiple sclerosis.
Review toxicities and potential long-term risks of oral agents used to treat relapsing-remitting multiple sclerosis.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Dr. Jeffery discloses that he has received honoraria for speaking and consulting from Bayer, Biogen-Idec, Teva, Serono, Novartis, Acorda, GSK, and Genzyme; and research support from Bayer, Biogen-Idec, Teva, Serono, Novartis, Acorda, and Genzyme.
Dr. Markowitz discloses that he has received research support from Bayer, Biogen-Idec, EMD Serono, Teva, Sanofi, Novartis, Opera, and Ono; and is a consultant for Bayer, Biogen-Idec, Teva, Novartis, and Genzyme.
Ms. Perrin Ross discloses that she is on the speakers bureau for Acorda, Bayer Healthcare, Pfizer, Teva, Questcor, Novartis; is a consultant for Allergan, Acorda, EMD Serono, Pfizer, Teva, Genzyme, Questcor, Novartis; and has received honoraria from Allergan, Acorda, Bayer Healthcare, EMD Serono, Pfizer, Teva, Genzyme, Questcor, Novartis.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Credit Statements
Physician Continuing Medical Education: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and MCM Education. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Continuing Education: AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
AKH Inc. designates this educational activity for 0.5 contact hour (0.05 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.
Nurse Practitioners: AKH Inc. is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. Provider number 030803. AKH Inc. designates this educational activity for 0.5 contact hour. Commercial Support Statements
There are no fees for participating in or receiving credit for this online educational activity.
Participants must view/listen to the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing education credit. Credit will be awarded for a score of 80% or better, and a statement may be printed immediately after passing the post-test online.
Review the intended audience, learning objectives, and author disclosures.
Study the educational activity, including the written, audio, and attached PDF content.
Once completed, please proceed to the post-activity survey and post-test.
Online, choose the best answer to each post-test question. To access this activity, users will need
• A computer with an Internet connection.
• Internet Explorer 6.x or higher, Firefox 2.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser. Certificate Fee